| Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease SJ Kish, J Tong, O Hornykiewicz, A Rajput, LJ Chang, M Guttman, ... Brain 131 (1), 120-131, 2007 | 455 | 2007 |
| Brain α-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation J Tong, H Wong, M Guttman, LC Ang, LS Forno, M Shimadzu, AH Rajput, ... Brain 133 (1), 172-188, 2009 | 213 | 2009 |
| Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region? SJ Kish, Y Furukawa, LJ Chang, J Tong, N Ginovart, A Wilson, S Houle, ... Nuclear medicine and biology 32 (2), 123-128, 2005 | 200 | 2005 |
| Distribution of monoamine oxidase proteins in human brain: implications for brain imaging studies J Tong, JH Meyer, Y Furukawa, I Boileau, LJ Chang, AA Wilson, S Houle Journal of Cerebral Blood Flow & Metabolism 33 (6), 863-871, 2013 | 197 | 2013 |
| Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[11C]DASB and structural brain imaging study SJ Kish, J Lerch, Y Furukawa, J Tong, T McCluskey, D Wilkins, S Houle, ... Brain 133 (6), 1779-1797, 2010 | 179 | 2010 |
| Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study I Boileau, D Payer, S Houle, A Behzadi, PM Rusjan, J Tong, D Wilkins, ... Journal of Neuroscience 32 (4), 1353-1359, 2012 | 176 | 2012 |
| Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders J Tong, G Rathitharan, JH Meyer, Y Furukawa, LC Ang, I Boileau, ... Brain 140 (9), 2460-2474, 2017 | 142 | 2017 |
| Heightened D3 Dopamine Receptor Levels in Cocaine Dependence and Contributions to the Addiction Behavioral Phenotype: A Positron Emission Tomography Study with … DE Payer, A Behzadi, SJ Kish, S Houle, AA Wilson, PM Rusjan, J Tong, ... Neuropsychopharmacology 39 (2), 321, 2014 | 119 | 2014 |
| Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naïve Parkinson's disease I Boileau, M Guttman, P Rusjan, JR Adams, S Houle, J Tong, ... Brain 132 (5), 1366-1375, 2009 | 118 | 2009 |
| Low levels of astroglial markers in Parkinson’s disease: relationship to α-synuclein accumulation J Tong, LC Ang, B Williams, Y Furukawa, P Fitzmaurice, M Guttman, ... Neurobiology of disease 82, 243-253, 2015 | 115 | 2015 |
| Brain serotonin transporter in human methamphetamine users SJ Kish, PS Fitzmaurice, I Boileau, GA Schmunk, LC Ang, Y Furukawa, ... Psychopharmacology 202 (4), 649, 2009 | 105 | 2009 |
| Increased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: is VMAT2 a stable dopamine neuron biomarker? I Boileau, P Rusjan, S Houle, D Wilkins, J Tong, P Selby, M Guttman, ... Journal of Neuroscience 28 (39), 9850-9856, 2008 | 105 | 2008 |
| Levels of 4-hydroxynonenal and malondialdehyde are increased in brain of human chronic users of methamphetamine PS Fitzmaurice, J Tong, M Yazdanpanah, PP Liu, KS Kalasinsky, SJ Kish Journal of Pharmacology and Experimental Therapeutics 319 (2), 703-709, 2006 | 104 | 2006 |
| [11C] CURB: Evaluation of a novel radiotracer for imaging fatty acid amide hydrolase by positron emission tomography AA Wilson, A Garcia, J Parkes, S Houle, J Tong, N Vasdev Nuclear medicine and biology 38 (2), 247-253, 2011 | 94 | 2011 |
| Mapping human brain fatty acid amide hydrolase activity with PET PM Rusjan, AA Wilson, R Mizrahi, I Boileau, SE Chavez, NJ Lobaugh, ... Journal of Cerebral Blood Flow & Metabolism 33 (3), 407-414, 2013 | 80 | 2013 |
| [11C]‐(+)‐PHNO PET imaging of dopamine D2/3 receptors in Parkinson's disease with impulse control disorders DE Payer, M Guttman, SJ Kish, J Tong, A Strafella, M Zack, JR Adams, ... Movement Disorders 30 (2), 160-166, 2015 | 76 | 2015 |
| The Fatty Acid Amide Hydrolase C385A Variant Affects Brain Binding of the Positron Emission Tomography Tracer [11C]CURB I Boileau, RF Tyndale, B Williams, E Mansouri, DJ Westwood, BL Foll, ... Journal of Cerebral Blood Flow & Metabolism 35 (8), 1237-1240, 2015 | 71 | 2015 |
| Brain dopamine neurone ‘damage’: methamphetamine users vs. Parkinson's disease–a critical assessment of the evidence SJ Kish, I Boileau, RC Callaghan, J Tong European Journal of Neuroscience 45 (1), 58-66, 2017 | 67 | 2017 |
| Fatty acid amide hydrolase binding in brain of cannabis users: imaging with the novel radiotracer [11C] CURB I Boileau, E Mansouri, B Williams, B Le Foll, P Rusjan, R Mizrahi, ... Biological psychiatry 80 (9), 691-701, 2016 | 64 | 2016 |
| Inverse relationship between brain noradrenaline level and dopamine loss in Parkinson disease: a possible neuroprotective role for noradrenaline J Tong, O Hornykiewicz, SJ Kish Archives of neurology 63 (12), 1724-1728, 2006 | 62 | 2006 |
